Further analysis of anti-LAIR1–treated GBM revealed that there were fewer M2-like TAMs and lower expression of M2-like TAM signature genes, including F13a1, which encodes factor XIII-A (FXIII-A). This evidence concerns the gene LAIR1 and glioblastoma.